Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Processing plate (Cobas, top view, with liquid)
[{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba929/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba929/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba92a/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba92a/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba92b/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba92b/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba92c/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba92c/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba92d/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba92d/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba92e/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba92e/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba92f/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba92f/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba930/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba930/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba931/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba931/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba932/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba932/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba933/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba933/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba934/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba934/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba935/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba935/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba936/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba936/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba937/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba937/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba938/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba938/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba939/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba939/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba93a/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba93a/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba93b/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba93b/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba93c/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba93c/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba93d/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba93d/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba93e/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba93e/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba93f/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba93f/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba940/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba940/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba941/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba941/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba942/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba942/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba943/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba943/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba944/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba944/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba945/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba945/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba946/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba946/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba947/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba947/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba948/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba948/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba949/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba949/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba94a/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba94a/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba94b/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba94b/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba94c/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba94c/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba94d/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba94d/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba94e/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba94e/668ef5b8f514a2d7ec1ba90e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/668ef610f514a2d7ec1ba94f/668ef5b8f514a2d7ec1ba90e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/668ef610f514a2d7ec1ba94f/668ef5b8f514a2d7ec1ba90e.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
processing plate,Cobas,sample processing,disposable plate,48 well,48,8x6,6x8,full,liquid,with liquid,high-throughput,barcoding,tracking,aliquoting,sample distribution,sample storage,integration,biological sample handling,clinical diagnostics,automated sample preparation,chemical resistance,precise fluid handling,contamination prevention,durable material,safety compliance,efficient workflow,sample integrity,multi-well format,types of experiments and applications:
molecular diagnostics,pcr preparation,clinical laboratory testing,infectious disease detection,genetic sequencing,blood sample processing,pathogen analysis,biochemical assays,pharmaceutical development,biomarker discovery,forensic sample analysis,microbial detection,environmental monitoring,cancer research,hematology studies,laboratory,research,equipment,machinery,technology,experiments,assay,well plate,microplate,microtiter plate,microtiter,multiwell,microwell,multiwell,plate,culture plate,culture,micro-dialysis,PCR protein,qPCR,hard shell,chamber,Polymerase chain reaction,thermal cycling,robotic handling,heat sealing,DNA binding,top,top view,superior,lab,laboratory,cobas,processing plate,sample processing,roche
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
